Pharmaron Beijing Co., Ltd. Class H (3759) Stock Statistics & Valuation Metrics

Pharmaron Beijing Co., Ltd. Class H has a market cap or net worth of HK$90.11B. The enterprise value is HK$39.54K.

Pharmaron Beijing Co., Ltd. Class H has 359,977,870 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharmaron Beijing Co., Ltd. Class H’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.84%.

The current PE Ratio of Pharmaron Beijing Co., Ltd. Class H is 45.5. Pharmaron Beijing Co., Ltd. Class H’s PEG ratio is -2.70.

In the last 12 months, Pharmaron Beijing Co., Ltd. Class H had revenue of 14.10B and earned 1.66B in profits. Earnings per share was 0.94.

In the last 12 months, operating cash flow was 2.95B and capital expenditures -2.90B, giving a free cash flow of 50.01M billion.

Pharmaron Beijing Co., Ltd. Class H pays an annual dividend of HK$0.23, resulting in a dividend yield of 0.74%

Pharmaron Beijing Co., Ltd. Class H upcoming earnings date is Oct 22, 2026, TBA (Not Confirmed).

Pharmaron Beijing Co., Ltd. Class H as a current ratio of 0.93, with Debt / Equity ratio of 42.53%

In the past 12 months, Pharmaron Beijing Co., Ltd. Class H has paid 357.52M in taxes.

Pharmaron Beijing Co., Ltd. Class H EV to EBITDA ratio is 10.16, with an EV/FCF ratio of 60.52.

Pharmaron Beijing Co., Ltd. Class H has HK$2.45B in cash and marketable securities with HK$6.95B in debt, giving a net cash position of -HK$4.50B billion.

Gross margin is 33.27%, with operating margin of 13.68%, and net profit margin of 11.80%.

The average price target for Pharmaron Beijing Co., Ltd. Class H is HK$37.08, which is 11.43% higher than the current price. The consensus rating is Strong Buy